RT @CSILabIoPPN: 📑New @DovePress paper co-authored by Sukhi Shergill @CSILabIoPPN on the Hummingbird Study @shanaya_rathod @hambahamba01 @S…
RT @CSILabIoPPN: 📑New @DovePress paper co-authored by Sukhi Shergill @CSILabIoPPN on the Hummingbird Study @shanaya_rathod @hambahamba01 @S…
RT @CSILabIoPPN: 📑New @DovePress paper co-authored by Sukhi Shergill @CSILabIoPPN on the Hummingbird Study @shanaya_rathod @hambahamba01 @S…
📑New @DovePress paper co-authored by Sukhi Shergill @CSILabIoPPN on the Hummingbird Study @shanaya_rathod @hambahamba01 @SHFT_Research ➡️ 8-week trial assessed a digital tool to measure medication ingestion among patients with psychotic disorders 🔗 https
RT @hambahamba01: Pleased to share the publication of the Hummingbird Study: Results from an Exploratory Trial Assessing the Per | NDT @Dov…
RT @hambahamba01: Pleased to share the publication of the Hummingbird Study: Results from an Exploratory Trial Assessing the Per | NDT @Dov…
RT @hambahamba01: Pleased to share the publication of the Hummingbird Study: Results from an Exploratory Trial Assessing the Per | NDT @Dov…
RT @hambahamba01: Pleased to share the publication of the Hummingbird Study: Results from an Exploratory Trial Assessing the Per | NDT @Dov…
Pleased to share the publication of the Hummingbird Study: Results from an Exploratory Trial Assessing the Per | NDT @DovePress https://t.co/mOUKNj6Mro @shanaya_rathod @SHFT_Research @Southern_NHSFT #innovation @NIHRCRNWessex @karlmarlowe
[Full text] Hummingbird Study: Results from an Exploratory Trial Assessing the Per | NDT - Dove Medical Press https://t.co/f5DwdluLGA